Edesa Biotech, Inc.

NASDAQ:EDSA

Biotechnology

Healthcare
$5.75 +1.31%

+$0.09 today

Market cap
$55.39M
Beta
1.07
P/E (TTM)
-5.5
EPS (TTM)
-$1.27
52W Low $0.72High $20.32

Volume 0.07M

Average 0.62M

Balance Sheet

Inspect the capital base behind the business.

Assets

$13.53M

FY 2025 · Annual

+254.8% YoY

Liabilities

$1.08M

FY 2025 · Annual

-41.2% YoY

Equity

$12.45M

FY 2025 · Annual

+528.5% YoY

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents7.84M7.09M5.36M1.04M10.79M
Short-term Investments00000
Net Receivables3.3M1.26M626.54K270.91K642.87K
Inventory00000
Other Current Assets948.65K745.54K448.91K367.39K77.84K
Total Current Assets12.09M9.09M6.44M1.68M11.51M
Property, Plant & Equipment (Net)111.56K31.16K100.08K18.36K0
Goodwill00000
Intangible Assets2.38M2.28M2.18M2.08M1.98M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0171.46K173.49K41.15K39.97K
Total Non-current Assets2.49M2.48M2.45M2.14M2.02M
Total Assets14.58M11.58M8.89M3.81M13.53M
Account Payables1.38M2.12M1.75M1.81M0
Short-term Debt00000
Tax Payables00000
Deferred Revenue0(2.12M)000
Other Current Liabilities02.12M001.08M
Total Current Liabilities1.46M2.14M1.82M1.83M1.08M
Long-term Debt00000
Deferred Tax Liabilities000126K0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities47.2K43.66K000
Total Non-current Liabilities67.71K43.66K19.77K126K0
Total Liabilities1.53M2.18M1.84M1.83M1.08M
Common Stock34.89M42.47M46.64M47.24M54.52M
Retained Earnings(26.5M)(44.04M)(52.42M)(58.59M)(65.91M)
Accumulated OCI(205.26K)(213.6K)(214.65K)(242.61K)(165.77K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity13.06M9.39M7.05M1.98M12.45M
Total Debt99.32K18.98K94.49K19.87K0
Net Debt(7.74M)(7.07M)(5.27M)(1.02M)(10.79M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$10.0M
Receivables$216.5K
Other Current$197.6K
Total Current Assets$10.4M
Intangible Assets$1.9M
Other Non-current$39.9K
Total Non-current Assets$2.0M
Total Assets$12.4M

Analysis

Selected assets total $12.4M for Latest. The largest visible component is Cash & Equivalents at $10.0M, about 80.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipAug 4, 2026
EFFECTEFFECT filingJul 13, 2026
424B3424B3 filingJul 13, 2026
4Statement of changes in beneficial ownershipJul 2, 2026
S-3S-3 filingJul 2, 2026

How much cash does EDSA have?

Edesa Biotech, Inc. (EDSA) reported $10.79M in cash and equivalents in fiscal 2025.

How much debt does EDSA carry?

Edesa Biotech, Inc. (EDSA) reported $0.00 of total debt, with net debt of -$10.79M.